Mediator and SAGA have distinct roles in Pol II preinitiation complex assembly and function.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3513640)

Published in Cell Rep on November 21, 2012

Authors

Xiao-Fen Chen1, Lynn Lehmann, Justin J Lin, Ajay Vashisht, Ryan Schmidt, Roberto Ferrari, Chengyang Huang, Robin McKee, Amber Mosley, Kathrin Plath, Siavash K Kurdistani, James Wohlschlegel, Michael Carey

Author Affiliations

1: Department of Biological Chemistry, David Geffen School of Medicine, University of California, BSRB 351A, 615 Charles E. Young Drive, Los Angeles, CA 90095-1737, USA.

Articles cited by this

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30

Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01

The role of chromatin during transcription. Cell (2007) 26.48

Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet (2008) 18.28

Mediator and cohesin connect gene expression and chromatin architecture. Nature (2010) 14.34

Deciphering the transcriptional histone acetylation code for a human gene. Cell (2002) 8.96

A map of the cis-regulatory sequences in the mouse genome. Nature (2012) 8.74

Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64

Identification and distinct regulation of yeast TATA box-containing genes. Cell (2004) 6.27

The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol (2006) 5.52

ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res (2011) 4.91

Mediator and the mechanism of transcriptional activation. Trends Biochem Sci (2005) 4.79

A genome-wide housekeeping role for TFIID and a highly regulated stress-related role for SAGA in Saccharomyces cerevisiae. Mol Cell (2004) 4.54

Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS. Mol Cell (2004) 4.20

Transcriptional coactivator complexes. Annu Rev Biochem (2001) 3.97

Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell (2008) 3.96

Redundant roles for the TFIID and SAGA complexes in global transcription. Nature (2000) 3.21

RNA polymerase II-TFIIB structure and mechanism of transcription initiation. Nature (2009) 2.98

Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. Biochim Biophys Acta (2010) 2.86

Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene (2007) 2.85

A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell (2006) 2.69

The Chd family of chromatin remodelers. Mutat Res (2007) 2.69

The super elongation complex (SEC) and MLL in development and disease. Genes Dev (2011) 2.63

Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell (2011) 2.53

Structure of an RNA polymerase II-TFIIB complex and the transcription initiation mechanism. Science (2009) 2.43

A human SPT3-TAFII31-GCN5-L acetylase complex distinct from transcription factor IID. J Biol Chem (1998) 2.40

Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev Biol (2009) 2.24

Characterization of human epigenomes. Curr Opin Genet Dev (2009) 2.17

Differential requirement of SAGA components for recruitment of TATA-box-binding protein to promoters in vivo. Mol Cell Biol (2002) 2.16

The SAGA continues: expanding the cellular role of a transcriptional co-activator complex. Oncogene (2007) 2.04

The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim Biophys Acta (2010) 2.03

Binding of TFIIB to RNA polymerase II: Mapping the binding site for the TFIIB zinc ribbon domain within the preinitiation complex. Mol Cell (2003) 1.85

STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. Mol Cell Biol (2007) 1.78

SAGA and ATAC histone acetyl transferase complexes regulate distinct sets of genes and ATAC defines a class of p300-independent enhancers. Mol Cell (2011) 1.68

Shifting players and paradigms in cell-specific transcription. Mol Cell (2009) 1.60

Function of a eukaryotic transcription activator during the transcription cycle. Mol Cell (2005) 1.60

Architecture of the RNA polymerase II preinitiation complex and mechanism of ATP-dependent promoter opening. Nat Struct Mol Biol (2012) 1.48

TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA. Genes Dev (2002) 1.45

Rtf1 is a multifunctional component of the Paf1 complex that regulates gene expression by directing cotranscriptional histone modification. Mol Cell Biol (2007) 1.40

Site-specific cross-linking of TBP in vivo and in vitro reveals a direct functional interaction with the SAGA subunit Spt3. Genes Dev (2008) 1.40

Positive and negative functions of the SAGA complex mediated through interaction of Spt8 with TBP and the N-terminal domain of TFIIA. Genes Dev (2004) 1.29

Mediator coordinates PIC assembly with recruitment of CHD1. Genes Dev (2011) 1.28

Origins and activity of the Mediator complex. Semin Cell Dev Biol (2011) 1.23

The SIRT2 deacetylase regulates autoacetylation of p300. Mol Cell (2008) 1.11

Reorganization of the host epigenome by a viral oncogene. Genome Res (2012) 1.10

Analysis of transcription factor-mediated remodeling of nucleosomal arrays in a purified system. Methods (1997) 1.01

Domains of Tra1 important for activator recruitment and transcription coactivator functions of SAGA and NuA4 complexes. Mol Cell Biol (2010) 1.01

Assembly of a mediator/TFIID/TFIIA complex bypasses the need for an activator. Curr Biol (2003) 0.96

A mammalian homolog of Drosophila melanogaster transcriptional coactivator intersex is a subunit of the mammalian Mediator complex. J Biol Chem (2003) 0.96

Biochemical mechanism of transcriptional activation by GAL4-VP16. Methods Enzymol (1996) 0.95

Endoplasmic reticulum stress-responsive transcription factor ATF6α directs recruitment of the Mediator of RNA polymerase II transcription and multiple histone acetyltransferase complexes. J Biol Chem (2012) 0.84

In vitro transcription and immobilized template analysis of preinitiation complexes. Curr Protoc Mol Biol (2012) 0.82

PICking apart Pol II initiation. Nat Struct Mol Biol (2012) 0.78

Articles by these authors

A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80

The role of chromatin during transcription. Cell (2007) 26.48

Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62

A role for the P-body component GW182 in microRNA function. Nat Cell Biol (2005) 7.54

Role of the murine reprogramming factors in the induction of pluripotency. Cell (2009) 7.46

Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell (2005) 7.21

Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16

Global histone modification patterns predict risk of prostate cancer recurrence. Nature (2005) 7.03

Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64

A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell (2009) 6.26

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 6.17

Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med (2014) 5.41

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 5.03

Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90

Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat Methods (2004) 4.62

Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell (2009) 4.57

Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases. Cell (2002) 4.38

Resting heart rate in cardiovascular disease. J Am Coll Cardiol (2007) 4.14

Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature (2009) 4.13

The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science (2013) 4.12

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation (2012) 4.09

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89

Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation (2003) 3.75

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50

Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev (2007) 3.43

Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. Genome Res (2009) 3.36

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet (2008) 3.36

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J (2004) 3.27

Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell (2009) 3.03

Day-surgery patients anesthetized with propofol have less postoperative pain than those anesthetized with sevoflurane. Anesth Analg (2009) 3.01

Requirement of Hos2 histone deacetylase for gene activity in yeast. Science (2002) 2.95

Proteomic analysis of murine Piwi proteins reveals a role for arginine methylation in specifying interaction with Tudor family members. Genes Dev (2009) 2.95

Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA (2005) 2.74

Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev (2009) 2.70

A mechanism for coordinating chromatin modification and preinitiation complex assembly. Mol Cell (2006) 2.69

Female human iPSCs retain an inactive X chromosome. Cell Stem Cell (2010) 2.59

Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells (2009) 2.51

Adenovirus small e1a alters global patterns of histone modification. Science (2008) 2.43

A case of liver trauma with a blunt regional anesthesia needle while performing transversus abdominis plane block. Reg Anesth Pain Med (2008) 2.43

Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol (2011) 2.39

Epigenetic reprogramming by adenovirus e1a. Science (2008) 2.38

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J (2012) 2.30

Global levels of histone modifications predict prognosis in different cancers. Am J Pathol (2009) 2.28

Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell (2009) 2.27

A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol Cell (2004) 2.27

Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics (2009) 2.15

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J (2005) 1.95

Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells. Stem Cells (2009) 1.94

Constraining G1-specific transcription to late G1 phase: the MBF-associated corepressor Nrm1 acts via negative feedback. Mol Cell (2006) 1.92

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J (2009) 1.91

Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation (2012) 1.87

Damage-induced phosphorylation of Sld3 is important to block late origin firing. Nature (2010) 1.86

Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med (2002) 1.86

Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells (2008) 1.83

Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell (2010) 1.81

CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation (2004) 1.77

Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73

Rtr1 is a CTD phosphatase that regulates RNA polymerase II during the transition from serine 5 to serine 2 phosphorylation. Mol Cell (2009) 1.68

The Nse5-Nse6 dimer mediates DNA repair roles of the Smc5-Smc6 complex. Mol Cell Biol (2006) 1.65

Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study. Circulation (2009) 1.62

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. Eur Heart J (2009) 1.60

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy. Eur Heart J (2005) 1.58

ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res (2006) 1.58

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol (2010) 1.57

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY). Eur Heart J (2013) 1.56

Pervasive and cooperative deadenylation of 3'UTRs by embryonic microRNA families. Mol Cell (2010) 1.55

Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. J Am Coll Cardiol (2007) 1.55

Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol (2007) 1.54

Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail (2005) 1.54

Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation (2005) 1.54

Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. Cardiovasc Res (2009) 1.53

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes. Eur J Heart Fail (2012) 1.53

Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA? Cardiovasc Drugs Ther (2008) 1.50

Sws1 is a conserved regulator of homologous recombination in eukaryotic cells. EMBO J (2006) 1.46

Cellular thiols redox status: a switch for NF-kappaB activation during myocardial post-ischaemic reperfusion. J Mol Cell Cardiol (2002) 1.45

TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA. Genes Dev (2002) 1.45

Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv (2011) 1.44

Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Cell (2012) 1.43

Post-translational regulation of Oct4 transcriptional activity. PLoS One (2009) 1.41

Effect of nolomirole on monocrotaline-induced heart failure. Pharmacol Res (2004) 1.41

Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res (2011) 1.41

Relative quantification of stable isotope labeled peptides using a linear ion trap-Orbitrap hybrid mass spectrometer. Anal Chem (2007) 1.40

Characterization of global yeast quantitative proteome data generated from the wild-type and glucose repression saccharomyces cerevisiae strains: the comparison of two quantitative methods. J Proteome Res (2008) 1.39

Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. Arch Cardiovasc Dis (2009) 1.39

X chromosome inactivation in the absence of Dicer. Proc Natl Acad Sci U S A (2009) 1.38

Mapping post-translational modifications of the histone variant MacroH2A1 using tandem mass spectrometry. Mol Cell Proteomics (2005) 1.38

Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol (2007) 1.36

Distinct functions of BMP4 during different stages of mouse ES cell neural commitment. Development (2010) 1.36

Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency. Nat Cell Biol (2013) 1.33

p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J (2006) 1.31

Histone acetylation regulates intracellular pH. Mol Cell (2012) 1.30